Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Botulinum Toxin for the Treatment of Involuntary Movement Disorders
This study is currently recruiting patients.
Sponsored by: | National Institute of Neurological Disorders and Stroke (NINDS) |
---|---|
Information provided by: | Warren G Magnuson Clinical Center (CC) |
Purpose
Botulism is a severe form of food poisoning caused by bacteria. This bacteria produces several toxins one of which is botulinum toxin A. This toxin causes the symptoms of food poisoning. Small amounts of botulinum toxin A have been used to treat speech disorders such as stuttering and problems with the muscles of the eyes.
The study examines the effectiveness of botulinum toxin as treatment for a variety of movement disorders. The goals of the study are to refine the technique of treatment to provide the best results, to improve the understanding of how botulinum toxin works on movement disorders, and find other conditions that may be treatable with botulinum toxin.
In addition, researchers also plan to study the possible use of botulinum toxin F alone and in combination with botulinum toxin A in patients who do not respond to botulinum A toxin treatment.
Condition | Treatment or Intervention |
---|---|
Chorea Drug Induced Dyskinesia Movement Disorder Muscular Disease Tic Disorder |
Drug: Botulinum Toxin |
MedlinePlus related topics: Mental Health; Movement Disorders; Muscle Disorders
Study Type: Interventional
Study Design: Training
Official Title: A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders
Expected Total Enrollment: 800
Study start: November 21, 1985
The efficacy of botulinum toxin (btx) has now been demonstrated for a variety of diseases associated with involuntary muscle spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the individual patient and specific techniques of injection. This protocol 1) provides for training of physicians in the use of botulinum toxin and 2) allows us to provide botulinum toxin injections for patients participating in other studies on physiology of dystonia, and other muscle spasms and physiological effects of botulinum toxin.
Eligibility
Genders Eligible for Study: Both
Criteria
Location and Contact Information
More Information
Publications
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |